Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07468123) titled 'Atrial Fibrillation Risk Estimation With Single-lead Handheld Electrocardiograms' on March 9.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Single (Outcomes Assessor).

Primary Sponsor: Massachusetts General Hospital

Condition: Atrial Fibrillation (AF)

Intervention: Diagnostic Test: 1L ECG screening

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: July 30, 2025

Target Sample Size: 200

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT074...